Bueno, C., Barrena, S., Bataller, A., Ortiz-Maldonado, V., Elliott, N., O'Byrne, S., . . . Menéndez, P. (2022). CD34+CD19-CD22+ B-cell progenitors might underlie phenotypic escape in patients treated with CD19-directed therapies. American Society of Hematology.
Chicago-referens (17:e uppl.)Bueno, C., et al. CD34+CD19-CD22+ B-cell Progenitors Might Underlie Phenotypic Escape in Patients Treated with CD19-directed Therapies. American Society of Hematology, 2022.
MLA-referens (9:e uppl.)Bueno, C., et al. CD34+CD19-CD22+ B-cell Progenitors Might Underlie Phenotypic Escape in Patients Treated with CD19-directed Therapies. American Society of Hematology, 2022.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.